03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Durel Forte* : | |
Type | Medicine Non Marketed |
Originator | Bi-Rodogyl |
Agent | Smart Pharma |
Distributor | Smart Pharma |
Laboratory | Substipharm Developpment |
Responsible Party | Substipharm Developpment |
Origin | France |
Manufacturer | Rottendorf Pharma |
Manufacturing Type | G |
Origin | France |
ATC | J01RA04 |
Durel Forte* :
Durel Forte* :
Durel Forte* :
Durel Forte* :
Durel Forte* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Acute generalised exanthematous pustulosis (AGEP) | Not known |
Agranulocytosis | Not known |
ALT increased | Not known |
Anaphylactic shock | Not known |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Anorexia | Not known |
AST increased | Not known |
Cardiac arrest | Not known |
Cephalea | Not known |
Cerebellar syndrome | Not known |
Color vision change | Not known |
Confusion | Not known |
Convulsion | Not known |
Cytolytic hepatitis | Very rare |
Delirium | Not known |
Depressed mood | Not known |
Diarrhoea (Diarrhea) | Common |
Diplopia | Not known |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Common |
Encephalopathy | Not known |
Epigastralgia (Epigastric pain) | Not known |
Eruption | Common |
Fixed pigmented erythema | Not known |
Flushing | Not known |
Gastralgia | Common |
Glossitis | Not known |
Haemolytic anemia | Not known |
Hallucination | Not known |
Hepatitis cholestatic | Not known |
Leucopenia (Leukopenia) | Not known |
Liver function test abnormal | Very rare |
Lyell Syndrome (Toxic epidermal necrolysis) | Not known |
Meningitis aseptic | Not known |
Myopia | Not known |
Nausea | Common |
Neuropathy | Not known |
Neutropenia | Not known |
Optic neuritis | Not known |
Pancreatitis | Not known |
Paraesthesia (paresthesia) | Very Common |
Peripheral sensorimotor neuropathy | Not known |
Phosphatase alkaline increased | Not known |
Pruritus | Not known |
Pseudomembranous colitis | Very rare |
Psychotic reactions | Not known |
QT interval prolonged (QT prolongation) | Not known |
Skin Eruption | Not known |
Stevens-Johnson syndrome | Not known |
Stomatitis | Not known |
Suicidal ideation | Not known |
Suicide | Not known |
Thrombocytopenia (Thrombopenia) | Not known |
Torsade de pointes | Not known |
Urticaria | Not known |
Ventricular arrhythmia | Not known |
Ventricular tachycardia | Not known |
Vertigo | Not known |
Vision blurred | Not known |
Visual acuity reduced | Not known |
Vomiting | Common |
NB : Products With Same Indication |
Different Units By MoH Code
Durel Forte* MoH 7407 :
Form | Tablet, Film-Coated |
Package Size | Box of 10 |
Strength | 250mg/1.5MIU |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 96747/12 |
Submission date | 01/01/2012 |
Registration Year | 2014 |
Archived Date | 2019 |
Price Comparison
You have to register to view this info
Drop File